← Open Payments lookup

BRIAN EKBERG: Open Payments

NPI 1992759583 · BOUNTIFUL, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,207 in 74 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $715 · 2025 $1,207

Food & beverage: $1,207
CompanyPaymentsAmount
ABBVIE INC.18$239
Lilly USA, LLC12$161
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$109
Amgen Inc.6$94
Janssen Pharmaceuticals, Inc3$74
Astellas Pharma US Inc4$71
GlaxoSmithKline, LLC.4$69
Otsuka America Pharmaceutical, Inc.4$65
AstraZeneca Pharmaceuticals LP4$60
Abbott Laboratories2$44

Products named: CAPLYTA, MOUNJARO, VRAYLAR, REXULTI, QULIPTA, SPRAVATO, UBRELVY, Veozah.

Industry payments across UT — which companies pay providers there.